Powles T, et al. A phase II study investigating the safety and efficacy of savolitinib and durvalumab in metastatic papillary renal cancer (CALYPSO). ASCO-GU 2019, abstract 545.
‘De werk-privé balans is beter, maar de zorg is stroperiger’
mei 2024
mrt 2024
nov 2023
sep 2023